Financial Statements — CGCTW
Balance Sheet
(in millions USD)| Metric | Q2
2026 | Q1
2026 | Q3
2025 | Q2
2025 | Q1
2025 |
|---|
| Cash & Equivalents | 112.83 | 0.00 | 0.00 | 0.00 | -- |
| Total Current Assets | 115.60 | 0.51 | 0.83 | 0.96 | -- |
| Property, Plant & Equipment | 19.22 | -- | -- | -- | -- |
| Total Non-current Assets* | 27.05 | 285.88 | 280.74 | 277.86 | -- |
| Total Assets | 142.65 | 286.39 | 281.56 | 278.82 | 0.71 |
| Accounts Payable | 0.72 | -- | -- | -- | -- |
| Total Current Liabilities | 6.60 | 1.39 | 0.40 | 0.42 | 0.74 |
| Total Non-current Liabilities* | 51.06 | 13.14 | 13.14 | 13.14 | 0.00 |
| Total Liabilities* | 57.66 | 14.53 | 13.54 | 13.56 | 0.74 |
| Retained Earnings | (275.49) | (14.01) | (12.65) | (12.51) | (0.06) |
| Total Stockholder Equity | 85.00 | (14.01) | (12.65) | (12.51) | (0.04) |
* Derived from reported values
Income Statement
(in millions USD) (except per-share rows)| Metric | Q2
2026 | Q1
2026 | Q4
2025 | Q3
2025 | Q2
2025 | Q1
2025 |
|---|
| Research & Development | 6.58 | -- | -- | -- | -- | -- |
| Selling, General & Admin | 6.38 | 0.81 | 0.55 | 0.14 | 0.45 | 0.02 |
| Total Operating Expenses | 12.96 | -- | -- | -- | -- | -- |
| Operating Income | (12.96) | (0.81) | (0.55) | (0.14) | (0.45) | -- |
| Pretax Income | (11.34) | -- | -- | -- | -- | -- |
| Tax Provision | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Income | (11.34) | 1.68 | 2.16 | 2.76 | 1.32 | (0.02) |
| Basic EPS | (0.61) | -- | -- | -- | -- | -- |
| Diluted EPS | (0.85) | -- | -- | -- | -- | -- |
Cash Flow Statement
(in millions USD)| Metric | Q2
2026 | Q1
2026 | Q4
2025 | Q3
2025 | Q2
2025 |
|---|
| Operating Cash Flow | (11.16) | (0.23) | (0.04) | (0.17) | (0.30) |
| Capital Expenditures | 0.56 | -- | -- | -- | -- |
| Free Cash Flow* | (11.72) | -- | -- | -- | -- |
| Investing Cash Flow | (0.58) | -- | 0.00 | 0.00 | (276.00) |
| Financing Cash Flow | 96.09 | -- | 0.00 | 0.00 | 277.13 |
* Derived from reported values
